Home4LN2 • FRA
add
Capricor Therapeutics Inc
Previous close
€6.41
Day range
€8.16 - €8.23
Year range
€3.35 - €20.45
Market cap
431.48M USD
Avg Volume
237.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.07M | 49.01% |
Net income | -24.39M | -149.04% |
Net profit margin | — | — |
Earnings per share | -0.53 | -70.97% |
EBITDA | -24.58M | -147.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 144.78M | 262.70% |
Total assets | 153.77M | 210.99% |
Total liabilities | 26.12M | -15.77% |
Total equity | 127.65M | — |
Shares outstanding | 45.71M | — |
Price to book | 2.30 | — |
Return on assets | -38.52% | — |
Return on capital | -45.29% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -24.39M | -149.04% |
Cash from operations | -6.43M | -407.20% |
Cash from investing | 23.89M | 351.43% |
Cash from financing | 50.35K | -97.80% |
Net change in cash | 17.51M | 306.45% |
Free cash flow | 1.09M | -26.43% |
About
CEO
Founded
2005
Website
Employees
160
